Tosoh Bioscience
Tosoh Bioscience, a leading name in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2003, the company has established itself as a key player in the development and manufacturing of high-quality chromatography products and bioprocessing solutions. With a focus on innovative technologies, Tosoh Bioscience offers a diverse range of core products, including affinity chromatography resins and analytical instruments, which are renowned for their reliability and performance. The company’s commitment to quality and customer satisfaction has solidified its market position, making it a trusted partner for laboratories and biopharmaceutical manufacturers worldwide. Notable achievements include significant advancements in protein purification and a robust portfolio that supports the evolving needs of the life sciences industry.
DitchCarbon Score
How does Tosoh Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tosoh Bioscience's score of 14 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tosoh Bioscience's reported carbon emissions
In 2022, Tosoh Bioscience reported total carbon emissions of approximately 89,341 kg CO2e, with emissions distributed across various scopes. The breakdown includes about 24,891 kg CO2e from Scope 1, primarily from mobile combustion, and about 677 kg CO2e from Scope 2. Notably, Scope 3 emissions accounted for a significant portion, reflecting activities such as employee commuting and waste generated in operations. Tosoh Bioscience has set an ambitious commitment to achieve net zero emissions by 2045, aiming for a substantial reduction of approximately 90% across all scopes. This long-term target underscores the company's dedication to addressing climate change and reducing its carbon footprint in alignment with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 316,972 | 00,000 |
| Scope 2 | 4,459 | 000 |
| Scope 3 | 47,681 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tosoh Bioscience is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
